ArticleTranslational oncology2022
Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation.
Asim Joshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleTranslational oncology2022
Asim Joshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.